Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden

Published:2020-04 Issue:4 Volume:287 Page:448-454
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Hultcrantz M.¹²^ORCID,Ravn Landtblom A.³,Andréasson B.⁴,Samuelsson J.⁵,Dickman P. W.⁶,Kristinsson S. Y.⁷⁸,Björkholm M.¹,Andersson T. M.‐L.⁶

Affiliation:

1. Department of Medicine, Solna Karolinska Institutet Stockholm Sweden

2. Myeloma Service Department of Medicine Memorial Sloan‐Kettering Cancer Center New York NY USA

3. Department of Medicine Stockholm South Hospital and Karolinska Institutet Stockholm Sweden

4. Hematology Section NU Hospital Group Uddevalla Sweden

5. Department of Hematology University Hospital Linkoping Linkoping Sweden

6. Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

7. Faculty of Medicine University of Iceland Reykjavik Iceland

8. Department of Hematology Landspitali National University Hospital Reykjavik Iceland

Funder

Radiumhemmets Forskningsfonder

Vetenskapsrådet

Stockholms Läns Landsting

Karolinska Institutet

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13019

Reference35 articles.

1. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

3. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders

4. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

5. Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial;International Journal of Hematology;2024-08-07

2. Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review;Current Issues in Molecular Biology;2024-08-02

3. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

4. Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.);Clinical Oncohematology;2024-07-01

5. Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature;British Journal of Haematology;2024-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3